Cargando…

Update on HER2-directed therapy

Detalles Bibliográficos
Autor principal:	Slamon, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233500/ http://dx.doi.org/10.1186/bcr1079

Ejemplares similares

Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
por: Slamon, DJ
Publicado: (2000)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Molecular mechanisms of resistance to HER2-targeted therapy
por: Esteva, FJ
Publicado: (2009)

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial
por: Rodenhuis, S, et al.
Publicado: (2005)

Role of HER2 in local relapse and metastasis
por: Ménard, S
Publicado: (2005)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Upregulation of ADAM proteases and HER ligands through a feedback loop mediates acquired resistance to trastuzumab in HER2-amplified breast cancer
por: Gijsen, M, et al.
Publicado: (2010)

CADET 2 results/computer-aided detection update
por: Gilbert, F
Publicado: (2008)

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
por: Ahmed, Nabil, et al.
Publicado: (2015)

Update on breast cancer genetics
por: Izatt, L
Publicado: (2006)

Update on the FH01 study
por: Duffy, SW
Publicado: (2006)

Comprehensive breast MRI: an update
por: Vinnicombe, Sarah J, et al.
Publicado: (2014)

Update on global HIV prevention research
por: Vermund, Sten H
Publicado: (2006)

ECLip-the European consortium on lipodystrophies: an update
por: Araújo-Vilar, David
Publicado: (2015)

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer
por: Baselga, J, et al.
Publicado: (2011)

Evaluation of digital mammography: update on the UK position
por: Cush, S
Publicado: (2006)

NICE family history guidance and implementation update
por: Mackay, J
Publicado: (2006)

Update on magnetic resonance screening and the MARIBS trial
por: Warren, R
Publicado: (2006)

S3.1a Update in mycetoma control
por: Fahal, Ahmed Hassan
Publicado: (2022)

Plantar heel pain: an update of its aetiology and diagnosis
por: Landorf, Karl B, et al.
Publicado: (2013)

Oncology update: what do all those acronyms mean?
por: Hughes-Davies, L
Publicado: (2006)

International cohort study for pediatric Behçet’s Disease: update 2011
por: Koné-Paut, I, et al.
Publicado: (2011)

The DICER1 familial cancer syndrome: clinical and molecular update
por: Deal, Cheri
Publicado: (2013)

Update from the Asia Pacific Malaria Elimination Network (APMEN)
por: Whittaker, Maxine
Publicado: (2012)

Ovarian cancer: imaging in treatment selection and planning with FIGO update
por: Sala, Evis
Publicado: (2014)

Ovarian cancer: imaging in treatment selection and planning with FIGO update
por: Sala, Evis
Publicado: (2015)

Update of Emerinopathies’ clinical-genetic spectrum: the French network experience
por: Leturcq, France, et al.
Publicado: (2015)

P357 Update on risk factors for Candida krusei-Fungemia
por: Jansen, Julia C., et al.
Publicado: (2022)

Update on CECR1 molecular diagnostics: new mutations in the deficiency of ADA2 (DADA2) and the North American polyarteritis nodosa (PAN) cohort
por: Stoffels, M, et al.
Publicado: (2015)

The influence of CONSORT on the quality of reporting of randomised controlled trials: an updated review
por: Turner, Lucy, et al.
Publicado: (2011)

SpineCore treatment for idiopathic scoliosis: updates and follow-up results.
por: Coillard, Christine, et al.
Publicado: (2010)

A common French-Italian laminopathy registry – update & future prospects
por: Bonne, Gisèle, et al.
Publicado: (2015)

The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds
por: Pironti, A, et al.
Publicado: (2010)

Updated evidence-based screening and treatment of osteoporosis in spinal cord injured patients
por: Maheronnaghsh, Radin, et al.
Publicado: (2012)

Clinical trial update: treatment of metastatic brain tumors using MRgFUS
por: Monteith, Stephen, et al.
Publicado: (2015)

B cell directed cytokines
por: Lipsky, Peter E
Publicado: (2011)

The Effect of Early Goal-Directed Therapy On Outcome in Adult Severe Sepsis And Septic Shock Patients: A Meta-Analysis of Randomised Clinical Trials
por: Xu, J, et al.
Publicado: (2015)

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
por: Humbert, Marc, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_meq9dmopst6s5qf06fji98p5kh